"Leica" Bond Ready-to-Use Primary Antibody Lambda Light Chain (SHL53) (Non-Sterile) - Taiwan Registration 2d4738aa36f4f15e5b5fc59a23fd69c7
Access comprehensive regulatory information for "Leica" Bond Ready-to-Use Primary Antibody Lambda Light Chain (SHL53) (Non-Sterile) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 2d4738aa36f4f15e5b5fc59a23fd69c7 and manufactured by LEICA BIOSYSTEMS NEWCASTLE LTD.. The authorized representative in Taiwan is BECKMAN COULTER TAIWAN INC., TAIWAN BRANCH (U.S.A.).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
2d4738aa36f4f15e5b5fc59a23fd69c7
Ministry of Health Medical Device Import No. 019577
DHA09401957701
Product Details
Limited to the first level identification range of immunopathological histochemical reagents and kits (B.1860) of the Measures for the Administration of Medical Devices.
B Hematology and pathology devices
B1860 Immunopathological histochemical reagents and kits
Imported from abroad
Dates and Status
Sep 06, 2018
Sep 06, 2028

